Related Experiment Video
Updated: Jan 31, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays
Jan P Wintgens1,2, Sven P Wichert1,2, Luksa Popovic2
1Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Nussbaumstr. 7, 80336, Munich, Germany.
Abstract:
Receptor tyrosine kinases (RTKs) play key roles in various aspects of cell biology, including cell-to-cell communication, proliferation and differentiation, survival, and tissue homeostasis, and have been implicated in various diseases including cancer and neurodevelopmental disorders. Ligand-activated RTKs recruit adapter proteins through a phosphotyrosine (p-Tyr) motif that is present on the RTK and a p-Tyr-binding domain, like the Src homology 2 (SH2) domain found in adapter proteins. Notably, numerous combinations of RTK/adapter combinations exist, making it challenging to compare receptor activities in standardised assays. In cell-based assays, a regulated adapter recruitment can be investigated using genetically encoded protein-protein interaction detection methods, such as the split TEV biosensor assay. Here, we applied the split TEV technique to robustly monitor the dynamic recruitment of both naturally occurring full-length adapters and artificial adapters, which are formed of clustered SH2 domains. The applicability of this approach was tested for RTKs from various subfamilies including the epidermal growth factor (ERBB) family, the insulin receptor (INSR) family, and the hepatocyte growth factor receptor (HGFR) family. Best signal-to-noise ratios of ligand-activated RTK receptor activation was obtained when clustered SH2 domains derived from GRB2 were used as adapters. The sensitivity and robustness of the RTK recruitment assays were validated in dose-dependent inhibition assays using the ERBB family-selective antagonists lapatinib and WZ4002. The RTK split TEV recruitment assays also qualify for high-throughput screening approaches, suggesting that the artificial adapter may be used as universal adapter in cell-based profiling assays within pharmacological intervention studies.
Insights
This study introduces a novel split TEV biosensor assay to monitor receptor tyrosine kinase (RTK) adapter protein recruitment. Clustered SH2 domains from GRB2 demonstrated superior performance, enabling robust cell-based profiling for drug discovery.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Pharmacology
Background:
- Receptor tyrosine kinases (RTKs) are crucial for cell signaling and implicated in diseases like cancer.
- RTK activation involves adapter protein recruitment via phosphotyrosine motifs, but diverse RTK/adapter combinations complicate standardized assays.
Purpose of the Study:
- To develop a robust, genetically encoded biosensor assay for monitoring dynamic RTK adapter protein recruitment.
- To evaluate the utility of artificial clustered SH2 domains as universal adapters in RTK signaling assays.
Main Methods:
- Application of the split TEV biosensor technique to detect protein-protein interactions in real-time.
- Testing the assay across different RTK families (ERBB, INSR, HGFR) using natural and artificial adapter proteins.
- Validation using dose-dependent inhibition assays with known RTK antagonists (lapatinib, WZ4002).
Main Results:
- The split TEV assay successfully monitored dynamic recruitment of both natural and artificial adapter proteins.
- Clustered SH2 domains derived from GRB2 provided the best signal-to-noise ratio for RTK activation.
- Assay sensitivity and robustness were confirmed in drug inhibition studies.
Conclusions:
- The split TEV recruitment assay is a sensitive and robust method for studying RTK signaling.
- Artificial adapters, particularly clustered GRB2 SH2 domains, can serve as universal components in cell-based RTK profiling.
- This approach is suitable for high-throughput screening and pharmacological intervention studies.
Related Concept Videos
Receptor Tyrosine Kinases
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Encoding
Automatic processing involves the encoding of details like time, space, frequency, and the meaning of words, usually done without conscious...
Receptor-mediated Endocytosis

